VTYX

Ventyx Biosciences Inc

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

VTYX price

Ventyx Biosciences Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VTYX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals VTYX

Valuation

P/E

0.00

Sector 7.81

Industry 7.81

P/BV

0.00

Sector 1.79

Industry 1.79

P/Revenue (PSR)

Sector 1.74

Industry 1.74

EV/EBITDA

Sector -161.97

Industry -161.97

EV/EBIT

Sector -507.85

Industry -507.85

P/EBITDA

Sector -9.63

Industry -9.63

P/EBIT

Sector -9.25

Industry -9.25

P/Total Assets

Sector 0.84

Industry 0.84

P/Net Current Assets

Sector -1.96

Industry -1.96

P/Working Capital

Sector -4,753.97

Industry -4,753.97

EPS

-1.50

Sector 0.73

Industry 0.73

BVPS

2.68

Sector 9.87

Industry 9.87

Efficiency

Gross Margin

0.00%

Sector 35.23%

Industry 35.23%

EBITDA Margin

Sector -260.17%

Industry -260.17%

EBIT Margin

Sector -7.46%

Industry -7.46%

Operating Margin

0.00%

Sector 4.29%

Industry 4.29%

Net Profit Margins

0.00%

Sector 2.72%

Industry 2.72%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-55.71%

Sector 2.52%

Industry 2.52%

ROA

-50.41%

Sector -0.66%

Industry -0.66%

ROIC

Sector -117.71%

Industry -117.71%

Dividends

Dividend yield

0.00%

Sector 0.52%

Industry 0.52%

Payout

Sector 9.86%

Industry 9.86%

Debt

Current Ratio

Sector 1.46

Industry 1.46

Net Debt / EBITDA

Sector -19.50

Industry -19.50

Net Debt / EBIT

Sector -166,485,085.47

Industry -166,485,085.47

Net Debt / Equity

Sector -0.76

Industry -0.76

Gross Debt / Equity

Sector -0.51

Industry -0.51

Equity/Assets

0.90

Sector 0.43

Industry 0.43

Liabilities/Assets

0.10

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

1.88%

Sector -

Industry -

Fundamentals VTYX

DRAG THE FRAME TO SEE MORE DATA

VTYX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ventyx Biosciences Inc

Ventyx Biosciences Inc

Average Investor10 user rating

4.0 (0 people)

United States

8 years

Founded: 2018

2021

Time since IPO - 5 years

83

Employees

Ventyx Biosciences Inc (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $191.36 million.

The company employs approximately 83 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Ventyx Biosciences Inc reported $- in revenue, generating net income of $-106.61 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VTYX.

Market cap

Net worth

$191.36 million

$191,364,000.00

Assets

$211.47 million

$211,465,000.00

Total Shares Outstanding

71.30 million

71,304,000

Average Daily Trading Volume

$748.43 Thousand

$748,426.00

Sector

Others

Industry

Others

VTYX

VTYX revenue and profits

Financial Results VTYX

DRAG THE FRAME TO SEE MORE DATA

VTYX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$371.34 8,36% (12M)

P/E

22.48

2.41%

ROE

14.27%

P/BV

3.21

SHEL - Shell PLC ADR

$95.95 37,99% (12M)

P/E

10.11

3.98%

ROE

14.29%

P/BV

1.44

STLA - Stellantis NV

$4.55 --52,80% (12M)

P/E

-0.55

0.00%

ROE

-35.93%

P/BV

0.20

COR - Cencora Inc.

$312.96 2,26% (12M)

P/E

22.65

0.78%

ROE

81.08%

P/BV

18.36

ALIZY - Allianz SE ADR

$47.61 --14,20% (12M)

P/E

13.94

2.69%

ROE

17.89%

P/BV

2.49

TTE - TotalEnergies SE ADR

$91.75 58,84% (12M)

P/E

7.30

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$94.18 9,87% (12M)

P/E

11.12

4.33%

ROE

58.05%

P/BV

6.46

ELV - Elevance Health Inc

$395.93 23,71% (12M)

P/E

20.04

1.69%

ROE

9.84%

P/BV

1.97